|
1
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harbuzariu A, Daley-Brown DS, Harmon TL,
Garrison RC, Beech DJ, Cason FD, Klug C and Gonzalez-Perez RR:
Abstract B26: Leptin affects proliferation, stem cells and
chemotherapeutic treatment outcome of pancreatic cancer: A link to
health disparity. Cancer Epidemiol Biomarkers Prev. 25:B262016.
|
|
4
|
Mendonsa AM, Chalfant MC, Gorden LD and
VanSaun MN: Modulation of the leptin receptor mediates tumor growth
and migration of pancreatic cancer cells. PLoS One.
10:e01266862015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ng M, Fleming T, Robinson M, Thomson B,
Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF,
et al: Global, regional, and national prevalence of overweight and
obesity in children and adults 1980–2013: A systematic analysis for
the Global Burden of Disease Study 2013. Lancet. 384:766–781. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inadera H: The usefulness of circulating
adipokine levels for the assessment of obesity-related health
problems. Int J Med Sci. 5:248–262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Luis DA, González Sagrado M, Conde R,
Aller R, Izaola O and Castro MJ: Circulating adipocytokines in
morbid obese patients, relation with cardiovascular risk factors
and anthropometric parameters. Nutr Hosp. 26:91–96. 2011.PubMed/NCBI
|
|
8
|
Ebert T, Roth I, Richter J, Tönjes A,
Kralisch S, Lossner U, Kratzsch J, Blüher M, Stumvoll M and
Fasshauer M: Different associations of adipokines in lean and
healthy adults. Horm Metab Res. 46:41–47. 2014.PubMed/NCBI
|
|
9
|
Balistreri CR, Caruso C and Candore G: The
role of adipose tissue and adipokines in obesity-related
inflammatory diseases. Mediators Inflamm. 2010:8020782010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collins S, Kuhn CM, Petro AE, Swick AG,
Chrunyk BA and Surwit RS: Role of leptin in fat regulation. Nature.
380:6771996. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lindheim SR, Sauer MV, Carmina E, Chang
PL, Zimmerman R and Lobo RA: Circulating leptin levels during
ovulation induction: Relation to adiposity and ovarian morphology.
Fertil Steril. 73:493–498. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Henson M and Castracane V: Leptin in
pregnancy. Biol Reprod. 63:1219–1228. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shaw RJ: Glucose metabolism and cancer.
Curr Opin Cell Biol. 18:598–608. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang G and Zhang BB: Glucagon and
regulation of glucose metabolism. Am J Physiol Endocrinol Metab.
284:E671–E678. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mueller WM, Gregoire FM, Stanhope KL,
Mobbs CV, Mizuno TM, Warden CH, Stern JS and Havel PJ: Evidence
that glucose metabolism regulates leptin secretion from cultured
rat adipocytes. Endocrinology. 139:551–558. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frühbeck G and Salvador J: Relation
between leptin and the regulation of glucose metabolism.
Diabetologia. 43:3–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morton GJ and Schwartz MW: Leptin and the
central nervous system control of glucose metabolism. Physiol Rev.
91:389–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ceddia RB: Direct metabolic regulation in
skeletal muscle and fat tissue by leptin: Implications for glucose
and fatty acids homeostasis. Int J Obes (Lond). 29:1175–1183. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vansaun MN: Molecular pathways:
Adiponectin and leptin signaling in cancer. Clin Cancer Res.
19:1926–1932. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cottrell EC and Mercer JG: Leptin
receptors. Handb Exp Pharmacol. 209:3–21. 2012. View Article : Google Scholar
|
|
21
|
Lin R, Ju H, Yuan Z, Zeng L, Sun Y, Su Z,
Yang Y, Wang Y and Jin L: Association of maternal and fetal LEPR
common variants with maternal glycemic traits during pregnancy. Sci
Rep. 7:31122017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hardwick JC, Van Den Brink GR, Offerhaus
GJ, Van Deventer SJ and Peppelenbosch MP: Leptin is a growth factor
for colonic epithelial cells. Gastroenterology. 121:79–90. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jaffe T and Schwartz B: Leptin promotes
motility and invasiveness in human colon cancer cells by activating
multiple signal-transduction pathways. Int J Cancer. 123:2543–2556.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saxena NK, Taliaferro-Smith LT, Knight BB,
Merlin D, Anania FA, O'Regan RM and Sharma D: Bidirectional
crosstalk between leptin and insulin-like growth factor-I signaling
promotes invasion and migration of breast cancer cells via
transactivation of epidermal growth factor receptor. Cancer Res.
68:9712–9722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fava G, Alpini G, Rychlicki C, Saccomanno
S, DeMorrow S, Trozzi L, Candelaresi C, Venter J, Di Sario A,
Marzioni M, et al: Leptin enhances cholangiocarcinoma cell growth.
Cancer Res. 68:6752–6761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Islam MS, Morton NM, Hansson A and
Emilsson V: Rat insulinoma-derived pancreatic beta-cells express a
functional leptin receptor that mediates a proliferative response.
Biochem Biophys Res Commun. 238:851–855. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan Y, Gan Y, Shen Y, Cai X, Song Y, Zhao
F, Yao M, Gu J and Tu H: Leptin signaling enhances cell invasion
and promotes the metastasis of human pancreatic cancer via
increasing MMP-13 production. Oncotarget. 6:16120–16134. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong JY, Kang B, Kim A, Hwang S, Ahn J,
Lee S, Kim J, Park JH and Cheon DS: Development of a highly
sensitive real-time one step RT-PCR combined complementary locked
primer technology and conjugated minor groove binder probe. Virol
J. 8:3302011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han G, Wang L, Zhao R, Yue Z, Zhou X, Hu
X, Cao Y, Dai D and Liu J: Leptin promotes human glioblastoma
growth through activating Signal Transducers and Activators of
Transcription 3 signaling. Brain Res Bull. 87:274–279. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Lv L, Xiao W, Gong C, Yin J, Wang D
and Sheng H: Leptin activates STAT3 and ERK1/2 pathways and induces
endometrial cancer cell proliferation. J Huazhong Univ Sci
Technolog Med Sci. 31:3652011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Endo H, Hosono K, Uchiyama T, Sakai E,
Sugiyama M, Takahashi H, Nakajima N, Wada K, Takeda K, Nakagama H
and Nakajima A: Leptin acts as a growth factor for colorectal
tumours at stages subsequent to tumour initiation in murine colon
carcinogenesis. Gut. 60:1363–1371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saxena NK, Vertino PM, Anania FA and
Sharma D: Leptin-induced growth stimulation of breast cancer cells
involves recruitment of histone acetyltransferases and mediator
complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem.
282:13316–13325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2010. View Article : Google Scholar
|
|
35
|
Somasundar P, McFadden DW, Hileman SM and
Vona-Davis L: Leptin is a growth factor in cancer. J Surg Res.
116:337–349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin-A growth factor in normal and malignant breast cells and for
normal mammary gland development. J Natl Cancer Inst. 95:1704–1711.
2002. View Article : Google Scholar
|
|
37
|
Dieudonne MN, Machinal-Quelin F,
Serazin-Leroy V, Leneveu MC, Pecquery R and Giudicelli Y: Leptin
mediates a proliferative response in human MCF7 breast cancer
cells. Biochem Biophys Res Commun. 293:622–628. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Krechler T, Zeman M, Vecka M, Macasek J,
Jachymova M, Zima T and Zak A: Leptin and adiponectin in pancreatic
cancer: Connection with diabetes mellitus. Neoplasma. 58:58–64.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lv X, Yao L, Zhang J, Han P and Li C:
Inhibition of microRNA-155 sensitizes lung cancer cells to
irradiation via suppression of HK2-modulated glucose metabolism.
Mol Med Rep. 14:1332–1338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao
Y, Feng Y, Li L, Wang Y, Liu X, et al: MicroRNA-143 (miR-143)
regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol
Chem. 287:23227–23235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fan R, Hou WJ, Zhao YJ, Liu SL, Qiu XS,
Wang EH and Wu GP: Overexpression of HPV16 E6/E7 mediated HIF-1α
upregulation of GLUT1 expression in lung cancer cells. Tumour Biol.
37:4655–4663. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sasaki H, Shitara M, Yokota K, Hikosaka Y,
Moriyama S, Yano M and Fujii Y: Overexpression of GLUT1 correlates
with Kras mutations in lung carcinomas. Mol Med Rep. 5:599–602.
2012.PubMed/NCBI
|
|
43
|
Huang L and Li C: Leptin: A
multifunctional hormone. Cell Res. 10:81–92. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ogunwobi O, Mutungi G and Beales IL:
Leptin stimulates proliferation and inhibits apoptosis in Barrett's
esophageal adenocarcinoma cells by cyclooxygenase-2-dependent,
prostaglandin-E2-mediated transactivation of the epidermal growth
factor receptor and c-Jun NH2-terminal kinase activation.
Endocrinology. 147:4505–4516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saxena NK, Sharma D, Ding X, Lin S, Marra
F, Merlin D and Anania FA: Concomitant activation of the JAK/STAT,
PI3K/AKT, and ERK signaling is involved in leptin-mediated
promotion of invasion and migration of hepatocellular carcinoma
cells. Cancer Res. 67:2497–2507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sharma D, Saxena NK, Vertino PM and Anania
FA: Leptin promotes the proliferative response and invasiveness in
human endometrial cancer cells by activating multiple
signal-transduction pathways. Endocr Relat Cancer. 13:629–640.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jóźwiak P, Krześlak A, Bryś M and Lipińska
A: Glucose-dependent glucose transporter 1 expression and its
impact on viability of thyroid cancer cells. Oncol Rep. 33:913–920.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hong SY, Yu FX, Luo Y and Hagen T:
Oncogenic activation of the PI3K/Akt pathway promotes cellular
glucose uptake by downregulating the expression of
thioredoxin-interacting protein. Cell Signal. 28:377–383. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hou X, Liu Y, Liu H, Chen X, Liu M, Che H,
Guo F, Wang C, Zhang D, Wu J, et al: PERK silence inhibits glioma
cell growth under low glucose stress by blockage of p-AKT and
subsequent HK2's mitochondria translocation. Sci Rep. 5:90652015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Neary CL and Pastorino JG: Akt inhibition
promotes hexokinase 2 redistribution and glucose uptake in cancer
cells. J Cell Physiol. 228:1943–1948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Stan SD, Singh SV and Brand RE:
Chemoprevention strategies for pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 7:347–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bloomston M, Zervos EE and Rosemurgy AS
II: Matrix metalloproteinases and their role in pancreatic cancer:
A review of preclinical studies and clinical trials. Ann Surg
Oncol. 9:668–674. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer-trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Vihinen P and Kähäri VM: Matrix
metalloproteinases in cancer: Prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
